FDA 483 - Meito Sangyo Co., Ltd - April 04, 2025

Meito Sangyo Co., Ltd in Nagoya, Japan, a manufacturer of human food and dietary supplements, was cited for significant deficiencies during an FDA inspection. The firm failed to establish adequate specifications for dietary supplement ingredients and finished products, lacked master manufacturing records, and maintained incomplete batch production records. Additionally, the facility exhibited unsanitary conditions and equipment in disrepair, posing risks to product quality and safety.